Vaccines and medicines for the world's poorest
BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7264.834 (Published 30 September 2000) Cite this as: BMJ 2000;321:834Quality of vaccines and medicines must be monitored
- Subhash C Arya, research physician (subhashji@hotmail.com)
- Centre for Logistical Research and Innovation, M-122 (of part 2), Greater Kailash-II, New Delhi-110048, India
- Cumbernauld, Glasgow G67 2BZ
EDITOR—Smith points to increasing international awareness about inadequate supplies of vaccines and drugs in tropical countries.1 Future private-public partnerships for better supply of vaccines and medicines for the world's poorest countries with “push” and “pull” mechanisms and financial allocation of billions of dollars by the American Congress would indeed imply adequate funds for researchers and others. Nevertheless, even that exorbitant fiscal input would provide little relief to many people living in tropical countries. Funds should be spared to monitor the quality of vaccines, drugs, and diagnostics in such countries.
There have been frequent reports of the poor quality of vaccines, drugs, and diagnostics in Asia, Africa, and Latin America. In Kelantan, a state in northwestern Malaysia, the contents of 14 of 33 phials of live poliovirus vaccine did not meet the criteria of a potent vaccine.2 Assay of active ingredients of tetracycline, co-trimoxazole, ampicillin-clavulanate, and chloroquine being offered to patients in Nigeria and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.